Gottlieb, Hargan, Owcharenko Join Trump's HHS Transition Team

Scott Gottlieb, former FDA deputy commissioner and resident fellow at the American Enterprise Institute, who has advocated for relaxation of FDA's limits of off-label uses of drugs and has said FDA policies are partly to blame for high drug prices, was named to President-elect Donald Trump's HHS Agency Landing Team Thursday (Dec. 1). Eric Hargan, shareholder at Greenberg Traurig LLP and former HHS deputy secretary, and Nina Owcharenko, director of the Center for Health Policy Studies at The Heritage Foundation,...